The newly proposed Microarray and Analysis Shared Services (MASS) is a comprehensive set of integrated gene expression services that facilitate studying the transcriptional regulation of genes in human tumors. The high throughput methodologies utilized in the MASS are closely linked to other institutional core laboratories [Basic Genomies and Proteomics Facility-(BGPF) and Clinical Proteomics Facility(CPF)] and also with Cancer Informatics Services (CIS), thereby providing a rich and integrated platform for basic and translational research at UPCI. MASS provides support and consultation for every step involved in a microarray experiment with human tissues (from experimental design to data analysis). MASS also works closely with the tissue banking component of the Tissue and Research Pathology Services (TARPS) to provide researchers the complete set of services to do gene expression studies as well as other related genomic techniques. The services offered by MASS currently include: 1) DNA and RNA extraction and quality assurance monitoring, 2) labeling, hybridization and scanning of commercially produced Affymetrix GeneChips or Amersham oligonucleotide DNA microarrays, 3) bioinformatics analysis services for all genomics and protcomics research at UPCI, and 4) storage, archival and network services to support the above applications and services. The funding requested will help to support the following needed expansion of MASS, to meet the needs of the UPCI membership: 1) custom spotted array printing services, 2) SNPs genotyping analysis, 3) develop and to provide a new service """"""""oligo-based quantitative human genome arrays"""""""" and 4) fully develop a LIMS system for genomic and proteomic data management across the three genomic and proteomic cores of the UPCI CCSG (BGPF and PF as well as MASS). The goal of MASS is to focus in the short to intermediate term on clinical and translational research needs and, in the longer term, to pursue developing into a Good Laboratory Practices facility (GLP) for large-scale population-based studies of promising cancer biomarkers for better detection, prognostication and treatment of human neoplasms. MASS will create a powerful environment for developing new diagnostic algorithms to predict aggressive tumors, identify potential therapeutic targets and also monitor (and enhance) tumor responses to therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA047904-20
Application #
7494671
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
20
Fiscal Year
2007
Total Cost
$308,935
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Li, Changfeng; Zhang, Ying; Cheng, Xing et al. (2018) PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. Dev Cell 46:441-455.e8
Welty, Starr; Teng, Yaqun; Liang, Zhuobin et al. (2018) RAD52 is required for RNA-templated recombination repair in post-mitotic neurons. J Biol Chem 293:1353-1362
Li, Xiang; George, Subin M; Vernetti, Lawrence et al. (2018) A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX. Lab Chip 18:2614-2631
Singh, Renu; Mehrotra, Shailly; Gopalakrishnan, Mathangi et al. (2018) Population pharmacokinetics and exposure-response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias. Cancer Chemother Pharmacol :
Nehmeh, Sadek A; Schwartz, Jazmin; Grkovski, Milan et al. (2018) Inter-operator variability in compartmental kinetic analysis of 18F-fluoromisonidazole dynamic PET. Clin Imaging 49:121-127
Woodcock, Chen-Shan Chen; Huang, Yi; Woodcock, Steven R et al. (2018) Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth. J Biol Chem 293:1120-1137
Posluszny, Donna M; Bovbjerg, Dana H; Syrjala, Karen L et al. (2018) Correlates of anxiety and depression symptoms among patients and their family caregivers prior to allogeneic hematopoietic cell transplant for hematological malignancies. Support Care Cancer :
Pulopulos, Matias M; Kozusznik, Malgorzata W (2018) The moderating role of meaning in life in the relationship between perceived stress and diurnal cortisol. Stress 21:203-210
Wang, Zehua; Yang, Bo; Zhang, Min et al. (2018) lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell 33:706-720.e9
Volonte, Daniela; Vyas, Avani R; Chen, Chen et al. (2018) Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence. J Biol Chem 293:1794-1809

Showing the most recent 10 out of 1187 publications